Article Correctness Is Author's Responsibility: The Josep Carreras Institute identifies a marker of poor evolution in Hodgkin’s lymphoma

(Josep Carreras Leukaemia Research Institute) Dr. Manel Esteller, director of the Josep Carreras Leukemia Research Institute, published today in Blood journal, the discovery of a marker that allows predicting which patient with Hodgkin's lymphoma will present the aggressive clinical course, and will therefore be a case of special risk.